2023 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
Director and Chief Executive Officer |
672.9 K |
-36.7 % |
2022 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
Director and Chief Executive Officer |
1.1 M |
-1.7 % |
2021 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
1.1 M |
120.9 % |
2021 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
Director and Chief Executive Officer |
1.1 M |
120.9 % |
2020 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
489.2 K |
-0.1 % |
2020 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
489.2 K |
-0.1 % |
2020 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
Director and Chief Executive Officer |
489.2 K |
-0.1 % |
2019 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
489.6 K |
4.9 % |
2019 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
489.6 K |
4.9 % |
2019 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
Director and Chief Executive Officer |
489.6 K |
4.9 % |
2018 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
466.6 K |
- |
2018 |
Cyclo Therapeutics Inc - Ordinary Shares - Class A
|
- |
466.6 K |
- |